Measures of morbidity in clinical studies with recurrent skeletal complications

Journal of Biopharmaceutical Statistics

Volumn 14, Issue 2, 2004, Pages 415-437

  Moecks, Joachim ^a,f   Koch, Gary G ^b   Scott, Martin ^c,g   Budde, Michael ^d   Givens, Samuel ^c   Koehler, Walter ^e   Knoessl, Michael ^c,h  

^a UNIVERSITY OF MANNHEIM   (Germany)

^b IL   (United States)

^c Roche Pharma Mannheim ^*  (United States)

^d F HOFFMANN LA ROCHE LTD   (Switzerland)

^e BaseLine   (Germany)

^f ROCHE DIAGNOSTICS GMBH   (Germany)

^g Serono AG   (Switzerland)

^h BAYER PHARMA AG   (Germany)

Author keywords

Composite endpoint; Morbidity measure; Recurrent rate; Unbalanced dropout

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; PLACEBO;

ADVANCED CANCER; ARTICLE; BIOASSAY; BONE DISEASE; BONE METASTASIS; BONE PAIN; CLINICAL RESEARCH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; EARLY DIAGNOSIS; FRACTURE; HUMAN; INCIDENCE; MORBIDITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SIMULATION; STATISTICAL ANALYSIS; TREATMENT OUTCOME; VALIDATION PROCESS;

BONE NEOPLASMS; HUMANS; RANDOMIZED CONTROLLED TRIALS; RECURRENCE;

EID: 2642530189     PISSN: 10543406     EISSN: None     Source Type: Journal    
DOI: 10.1081/BIP-120037190     Document Type: Article

References (20)

1. Albert, P. S., Follmann, D. A. (2000). Modeling repeated count data subject to informative dropout. Biometrics 56:667-677.
2. Anderson, P. K., Borgan, O., Gill, R. D., Keiding, N. (1993). Statistical Methods Based on Counting Processes. New York: Springer Verlag, p. 184.
3. Anscombe, F. J. (1956). On estimating binomial response relations. Biometrika 43:461-464.
4. Berenson, J. R., Lichtenstein, A., Porter, L., Dimopoulos, M. A., Bordoni, R., George, S., Lipton, A., Keller, A., Ballester, O., Kovacs, M., Blacklock, H., Bell, R., Simeone, J. F., Reitsma, D. J., Heffernan, M., Seaman, J. J., Knight, R. D. (1998). Long term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events. J. Clin. Oncol. 16:593-602.
5. Cook, R. J., Lawless, J. F. (1997). Marginal analysis of recurrent events and a terminating event. Statist. Med. 16:911-924.
6. Cook, R. J., Major, P. (2001). Methodology for treatment evaluation in patients with cancer metastatic to bone. J. Natl. Cancer Instit. 7:534-538.
7. Cox, D. R., Hinkley, D. V. (1974). Theoretical Statistics. London: Chapman and Hall, p. 53.
8. Gart, J. J., Zweifel, J. R. (1967). On the bias of various estimators of the logit and its variance with application to quantal bioassay. Biometrika 54:181-187.
9. Haldane, J. B. S. (1955). The estimation and significance of the logarithm of a ratio of frequencies. Ann. Hum. Genet. 20:309-311.
10. Hortobagyi, G. N., Theriault, R. L., Lipton, A., Porter, L., Blayney, D., Sinoff, C., Wheeler, H., Simeone, J. F., Seaman, J. J., Knight, R. D., Heffernan, M., Mellars, K., Reitsma, D. J. (1998). Long-term prevention of skeletal complications of metastatic breast cancer with pamidronate. J. Clin. Oncol. 16:2038-2044.
11. Koch, G. G., Tangen, C. M. (1999). Non-parametric analysis of covariance and its role in non-inferiority clinical trials. Drug Inform. J. 33:1145-1159.
12. Koch, G. G., Carr, G. J., Amara, I. A., Stokes, M. E., Uryniak, T. J. (1990). Categorical data analysis. In: Statistical Methodology in the Pharmaceutical Sciences. New York: Marcel Dekker, pp. 398-472.
13. Koch, G. G., Tangen, C. M., Jung, J. W., Amara, I. A. (1998). Issues for covariance analysis of dichotomous and ordered categorical data from randomized clinical trials and non-parametric strategies for addressing them. Statist. Med. 17:1863-1892.
14. Lawless, J. F., Nadeau, C. (1995). Some simple robust methods for the analysis of recurrent events. Technometrics 2:158-168.
15. Mahé, C., Chevret, S. (1999). Estimation of the treatment effect in a clinical trial when recurrent events define the endpoint. Statist. Med. 18:1821-1829.
16. Moecks, J. (2000). Cardiovascular mortality in haemodialysis patients treated with erythropoietin-a retrospective study. Nephron 86:455-462.
17. Stukel, T. A., Glynn, R. J., Fisher, E. S., Sharp, S. M., Lu-Yao, G., Wennberg, J. E. (1994). Standardized rates of recurrent outcomes. Statist. Med. 13:1781-1791.
18. Thall, P. F., Lachin, J. M. (1988). Analysis of recurrent events: Nonparametric methods for random-interval count data. J. Amer. Statist. Assoc. 402:339-347.
19. Therneau, T. M., Hamilton, S. A. (1997). RhDNase as an example of recurrent event analysis. Statist. Med. 16:2029-2047.
20. Zeger, S. L., Liang, K. Y. (1986). Longitudinal data analysis for discrete and continuous outcomes. Biometrics 42:121-130.